Nanalysis Scientific (TSXV:NSCI) COGS-to-Revenue : 0.79 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific COGS-to-Revenue?

Nanalysis Scientific's Cost of Goods Sold for the three months ended in Mar. 2024 was C$8.81 Mil. Its Revenue for the three months ended in Mar. 2024 was C$11.16 Mil.

Nanalysis Scientific's COGS to Revenue for the three months ended in Mar. 2024 was 0.79.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Nanalysis Scientific's Gross Margin % for the three months ended in Mar. 2024 was 21.08%.

Nanalysis Scientific COGS-to-Revenue Historical Data

The historical data trend for Nanalysis Scientific's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific COGS-to-Revenue Chart

Nanalysis Scientific Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.28

0.34

0.36

0.58

0.86

Nanalysis Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															1.01	0.82	0.77	0.82	0.79

Nanalysis Scientific COGS-to-Revenue Calculation

Nanalysis Scientific's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	24.495	/	28.466
	=	0.86

Nanalysis Scientific's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	8.809	/	11.162
	=	0.79

Nanalysis Scientific (TSXV:NSCI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Nanalysis Scientific's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	8.809 / 11.162
	=	21.08 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Nanalysis Scientific COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanalysis Scientific (TSXV:NSCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

NSCIF:USA 1N1:Germany

Address

Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3

Website

https://www.nanalysis.com

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.

Executives

Michal Okoniewski

Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines